ArticleNeuro-oncology practice2024

Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of Alberta.

Egiroh Omene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.